This antibody bound A431 cells >100-fold less potently (Fig. 1A), suggesting that the bivalent format of XmAb808 drives avid binding to cancer cells expressing higher B7-H3 levels relative to normal cells with lower levels. This evidence concerns the gene CD276 and cancer.